• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Multi-component sleep-mood group interventions may improve insomnia symptoms in young adults

byJayden BerdugoandAlex Chan
November 14, 2024
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this pilot randomized controlled trial, the Sleep Mood Intervention: Life Effectively (SMILE) intervention was associated with improvements in insomnia in university students.

Evidence rating level: 1 (Excellent)

Insomnia has a major burden on public health and can have serious long-term physical and mental health effects if left untreated. A population at a high risk for sleep problems include university students which may be due to specific challenges that arise during this phase in life as balancing stress and developing greater independence. There is much research to support the use of cognitive behavioural therapy for insomnia (CBT-I), involving changing negative attitudes through the use of cognitive restructuring. In addition to CBT-I, mindfulness interventions, promoting being present in the moment, have promising results, specifically on reducing stress and anxiety. To study the effectiveness of mindfulness counselling on insomnia in university students, a randomized controlled trial created the Sleep Mood Intervention: Life Effectively (SMILE) intervention. The participants were assigned to the SMILE intervention group and a waiting list control group is a 2:1 ratio. The participants completed the Insomnia Severity Index (ISI) and those with a score of ≥ 10 were eligible for further screening including a face-to-face diagnostic interview using the M.I.N.I Plus International Neuropsychiatric Interview. Several inclusion criteria were listed including self-reported sleep complaints (ISI score ≥ 10), university enrollment, 18 years or older, English proficiency, and willing to participate in a 4-week program. After randomization, 23 people were assigned to the SMILE group and 12 were assigned to the waitlist group. Outcomes were assessed at baseline and after five weeks. Insomnia was assessed using the ISI, while depression was assessed using the Beck Depression Inventory II, and anxiety was assessed using the Hospital Anxiety and Depression Scale (HADS-A). The participants in the SMILE group had significantly lower severity levels of insomnia (M = 10.7, SD = 4.8) compared to the waitlist group (M = 14.7, SD = 4.9), post-test (t (33) = 2.33; p = .03, [95% CI: 0.51 to 7.52]. The impact of the SMILE intervention effects on insomnia severity was mediated by dysfunctional beliefs, with a reduction in dysfunctional beliefs associated with a decrease in insomnia severity, b = 1.12, [95% CI: -2.58 to -0.06]. There were no significant effects found for depression, d = 0.02 [95% CI: -0.35 tp 0.37], anxiety, d = 0.15 [95% CI: -0.16 to 0.53] and quality of life, d = 0.09 [95% CI: -0.25 to 0.42]. Overall, university students struggling with insomnia experienced improvements in their symptoms after participating in the four-week SMILE intervention.  

Click to read the study in BMC Psychology

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

Oral semaglutide reduces cardiovascular event rates in high-risk patients

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

Tags: chronic diseasecounsellingInsomniapsychiatrypsychology
Previous Post

Direct oral anticoagulant scores predict bleeding risk in patients undergoing transcatheter valve replacement

Next Post

#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

RelatedReports

Multiple-electrode switching radiofrequency ablation may successfully treat lung tumors
Cardiology

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

June 5, 2025
Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients
Cardiology

Oral semaglutide reduces cardiovascular event rates in high-risk patients

June 5, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Sleep duration inversely related to childhood type 2 diabetes risk makers
Chronic Disease

Midlife weight loss is associated with decreased risk of mortality and chronic disease

June 3, 2025
Next Post
#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

Plasma progranulin levels are correlated with left ventricular function recovery following myocardial infarction

American Academy of Pediatrics recommends standards for adverse event disclosures

Pressure-mediated biofeedback with pelvic floor muscle training for urinary incontinence

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous hydrocortisone may reduce risk of kidney failure in patients with sepsis
  • Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension
  • Oral semaglutide reduces cardiovascular event rates in high-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.